Glioma research has rapidly evolved in recent years, particularly in the context of diagnostic imaging and personalized ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Lauren writes about healthcare AI data interoperability, the science behind public health recommendations, and pharmaceutical advances in the rare disease space. In a rare move, nonprofit organization ...

ANN ARBOR, MI — A University of Michigan Health center is using artificial intelligence to help plan treatments for prostate cancer. The UM Health Weiser Center for Prostate Cancer in Ann Arbor ...

Recombinant adeno-associated virus (AAV) vectors are predominantly nonintegrating, but rare genomic integration events have been associated with oncogenesis in neonatal murine models. Here we report a ...

Data scarcity and class imbalance remain critical challenges in medical image analysis, particularly for brain tumor MRI segmentation, where subcomponents such as enhancing tumor, non-enhancing tumor, ...

A research team led by the University of Michigan College of Pharmacy and the University of Texas MD Anderson Cancer Center has developed a new type of nanoparticle therapy that could make cancer ...

While part one established the strategic value of defining target client profiles and building a thoughtful client segmentation model, the real transformation begins when firms put those insights into ...

Israeli Prime Minister Benjamin Netanyahu was treated for early-stage prostate cancer 18 months ago, he revealed Friday, saying he delayed making the news public so Iran would not use it as ...

When Garry Buettner, PhD, who has been studying the chemistry and biochemistry of vitamin C for at least four decades, was diagnosed with myelodysplastic syndromes (MDS), he applied his research to ...

Multicentric Validation of a Complete Blood Count–Based Model for Breast Cancer Risk Stratification in Women Age 40-49 Years AI segmentation using Segment Anything Model 2 (SAM 2) was evaluated from ...